BELLUSCURA PLC Logo

BELLUSCURA PLC

Develops portable oxygen concentrators for patients needing supplemental oxygen.

BELL | IL

Overview

Corporate Details

ISIN(s):
GB00BD3B8Z11 (+2 more)
LEI:
213800BRJQZE56XBPW94
Country:
United Kingdom
Address:
15 FETTER LANE, EC4A 1BW LONDON
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Belluscura PLC is a medical device company focused on developing and manufacturing advanced oxygen enrichment technologies to improve the quality of life for patients requiring supplemental oxygen. The company's principal products are its lightweight and compact portable oxygen concentrators (POCs), including the FDA-cleared X-PLOR® and the DISCOV-R™. These devices are engineered with proprietary technologies, such as the patented ModulAir™ system and an 'Airgonomical™' design, to provide greater mobility and independence than traditional oxygen tanks. Belluscura aims to help patients with lung diseases lead healthier and more active lives through its innovative and approachable oxygen therapy solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-05 11:00
Legal Proceedings Report
Intention to appoint Administrator Update
English 7.7 KB
2025-10-31 13:15
Legal Proceedings Report
Intention to appoint Administrator
English 12.7 KB
2025-10-30 12:30
Legal Proceedings Report
Replacement Statement re US Subsidiary Update
English 13.5 KB
2025-10-30 11:38
Legal Proceedings Report
Statement re US Subsidiary Chapter 7 Update
English 12.6 KB
2025-09-22 08:00
Capital/Financing Update
Directorate Change
English 17.6 KB
2025-09-12 17:57
Board/Management Information
Board Appointment
English 21.1 KB
2025-08-11 08:00
Capital/Financing Update
Update re Strategic Review and Proposed Fundraise
English 14.2 KB
2025-06-30 08:00
Capital/Financing Update
Strategic Review Update and Proposed Fundraising
English 19.3 KB
2025-06-19 12:07
Major Shareholding Notification
Holding(s) in Company - Replacement
English 52.5 KB
2025-06-18 18:01
Major Shareholding Notification
Holding(s) in Company
English 52.0 KB
2025-03-27 16:15
Major Shareholding Notification
Holding(s) in Company
English 52.1 KB
2025-03-10 18:49
Major Shareholding Notification
Holding(s) in Company
English 52.4 KB
2025-03-06 17:21
Major Shareholding Notification
Holding(s) in Company
English 22.8 KB
2025-03-06 14:08
Major Shareholding Notification
Holding(s) in Company
English 52.4 KB
2025-03-05 15:21
Major Shareholding Notification
Holding(s) in Company
English 21.7 KB

Automate Your Workflow. Get a real-time feed of all BELLUSCURA PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BELLUSCURA PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BELLUSCURA PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Safe S.A. Logo
Appears to operate in the orthopedics sector; specific details are unavailable.
France
ALSAF
Sanara MedTech Inc. Logo
Develops med-tech for surgical, wound, and skin care, plus telehealth for providers.
United States of America
SMTI
SANYU CO.,LTD. Logo
A manufacturer of medical analytical equipment focused on R&D for next-generation systems.
Japan
5697
Scandinavian ChemoTech AB Logo
Develops electroporation tech to enhance chemotherapy for cancer, targeting Asia & the Middle East.
Sweden
CMOTEC
Scandinavian Real Heart AB Logo
Develops a total artificial heart that mimics natural heart function for heart failure patients.
Sweden
HEART
Schott Pharma Logo
Drug containment & delivery systems (syringes, vials) for the global pharma/biotech industry.
Germany
1SXP
SD BIOSENSOR  INC. Logo
South Korea
137310
SeaStar Medical Holding Corp Logo
Develops a device-based therapy for hyperinflammation in critically ill ICU patients.
United States of America
ICU
SEJONG MEDICAL Co.Ltd., Logo
South Korea
258830
Senseonics Holdings, Inc. Logo
Develops the first long-term, implantable glucose sensor for diabetes management.
United States of America
SENS

Talk to a Data Expert

Have a question? We'll get back to you promptly.